TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Escin, Cisplatin
Phytochemical Name Escin (PubChem CID: 16211024 )
Anticancer drug Name Cisplatin (PubChem CID: 5702198 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 942
Pair Name Escin, Cisplatin
Disease Info [ICD-11: 2C60] Breast cancer Investigative
Biological Phenomena Induction-->Ferroptosis
Gene Regulation Down-regulation Expression G6PD hsa2539
Down-regulation Expression GPX4 hsa2879
In Vitro Model MCF-7 Invasive breast carcinoma of no special type Homo sapiens (Human) CVCL_0031
MDA-MB-231 Breast adenocarcinoma Homo sapiens (Human) CVCL_0062
In Vivo Model MDA-MB-231 cells (2.5×10⁶ cells per mouse) stably expressing sh-NC and sh-G6PD were established.When the tumor grew to approximately 60 mm3, 2 mg/kg Escin was intraperitoneally injected with normal saline as the control.
Result Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin
03. Reference
No. Title Href
1 Role of Escin in breast cancer therapy: potential mechanism for inducing ferroptosis and synergistic antitumor activity with cisplatin. Apoptosis. 2023 Aug;28(7-8):1154-1167. doi: 10.1007/s10495-023-01849-x. Click
It has been 47260 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP